Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.

Also called NCT02070679

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 284 participants (enrolled count) (from the registry)
Sponsor
Urmia University of Medical Sciences (from the registry)
Registry
  • NCT NCT02070679
Other papers using this trial's data
  • Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial Journal of the American Heart Association, 2016-03-15 DOI, PubMed 27068631, PMC4943266 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02070679. Randomized; triple masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
Condition
Stable Angina
Condition
Unstable Angina
Condition
Non ST Segment Elevation Myocardial Infarction
Condition
Post MI
Intervention (Drug)
Vitamin E
Lead sponsor
Urmia University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct02070679
Content hash
2ccbcea43299f11e6c68d5b799e647fd267f84367f49041968a4ac983d9ffd05